MIT Holding, Inc. (MITD) Partnership Commences Treatment of Patients in Phase 3 FDA Clinical Trial With SERRG | Publicwire

MIT Holding, Inc. (OTCQB: MITD) announces the intake of patients for a FDA clinical trial.
http://bit.ly/1vtynzq